Skip to main content

Want a detailed portfolio tracker?

SOPHiA Genetics (SOPH) Free Cash Flow (2020 - 2026)

SOPHiA Genetics (SOPH) free cash flow from Mar 31, 2020 to Mar 31, 2026. The TTM SOPHiA Genetics (SOPH) free cash flow is -$45M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual Free Cash Flow

Quarterly Free Cash Flow

SOPHiA Genetics (SOPH) Free Cash Flow CAGR table

PeriodCAGR
1 Year TTM-2.57%
3 Years TTM-16.30%
5 Years TTM+3.57%
All Time TTM+3.57%

Annual Free Cash Flow change of SOPHiA Genetics (SOPH)

YearFree Cash FlowChange
2026-$17M-55.78%
2025-$39M-24.35%
2024-$51M-11.76%
2023-$58M-28.17%
2022-$80M+24.55%
2021-$65M+84.97%
2020-$35M+0.63%
2019-$35MN/A

Comparison SOPHiA Genetics (SOPH) five years free cash flow CAGR with competitors

SOPHiA Genetics (SOPH) five years free cash flow CAGR is 3.56%.

TickerNamefive years Free Cash Flow CAGRUpside
CCLDCareCloud Inc102.20%+2768.75%
CCLDOCareCloud Inc102.20%+2768.75%
DOCSDoximity Inc - Class A31.59%+786.79%
PRVAPrivia Health Group Inc26.19%+635.13%
HQYHealthequity Inc21.98%+516.98%
VEEVVeeva Systems Inc - Class A20.75%+482.50%
SLPSimulations Plus Inc20.27%+468.90%
CERTCertara Inc17.14%+381.11%
HSTMHealthstream Inc5.47%+53.48%
PINCPremier Inc - Class A3.22%-9.62%
SPOKSpok Holdings Inc2.62%-26.50%
DRIODarioHealth Corp1.27%-64.39%